Tacrolimus(104987-11-3)
- Name: Tacrolimus
- Synonyms:4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-heptadecahydro-5,19-dihydroxy-3-;FK-506;FK506;15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine- 1,7,20,21(4H,23H)-tetrone,5,6,8,11,- 12,13,14,15,16,17,18,19,24,25,26,26ahexadecahydro- 5,19-dihydroxy-3-[(1E)-2- [(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]- 1-methylethenyl]-14,16-dimethoxy-4,10,12,18- tetramethyl-8-(2-propenyl)-,(3S,4R,5S,8R,- 9E,12S,14S,15R,16S,18R,19R,26aS)-;FR 900506;Prograf;dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-,(3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS)-;FK 506;Fujimycin;FR-900506;[(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-;Tacrolimus (FK506);Tacrolimus(FK-506);Tacrolimus(FK506);Tacrolimus, FK-506;Taccrolimus;Tacrolimus [GMP];15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,;Prograde metamorphismPrograf;
- Molecular Formula:C44H69NO12
- Molecular Weight:804.031
- CAS Registry Number:104987-11-3
- EINECS:1308068-626-2
- Melting Point:113-115 °C
- Water Solubility:DMSO: >3 mg/mL
- Afine Chemicals Limited
- Sinoway Industrial Co., Ltd.
- Simagchem Corporation
- shanghai Tauto Biotech Co., Ltd
- Chengdu Biopurify Phytochemicals Ltd.
- CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
- Dayang Chem (Hangzhou) Co.,Ltd.
- Hangzhou Sartort Biopharma Co., Ltd
- Josun International Limited
- HENAN NEW BLUE CHEMICAL CO.,LTD
- Wuhan Fortuna Chemical Co.,Ltd
- SHANGHAI T&W PHARMACEUTICAL CO., LTD.
- Hangzhou Hysen Pharma co.,Ltd.
- LIDE PHARMACEUTICALS LIMITED
- Shanghai Hope Chem Co., Ltd
- Xiamen Hisunny Chemical Co.,Ltd
- BOC Sciences

Other Product
- 3153-44-4/3-(4-Methoxybenzoyl)propionic acid
- 136122-46-8/UP 116-77
- 5809-04-1/6-phenyl-2-(prop-2-yn-1-ylsulfanyl)-4-(trifluoromethyl)pyridine-3-carbonitrile
- 37250-75-2/Dehydrogenase,21-hydroxy steroid
- 42848-06-6/Methyl(E)-1-propenyl sulfide
- 89886-42-0/9(S)-HOT
- 58199-96-5/8-Desacetyl-8-carboxy Daunorubicin Hydrochloride
- 142569-89-9/4,8-Epoxyazulen-5-ol,decahydro-5,8a-dimethyl-3-(1-methylethyl)-, (3R,3aR,4S,5S,8S,8aS)-rel-(-)-
- 6154-06-9/N-(2-methyl-2H-tetrazol-5-yl)acetamide
- 72133-67-6/Picolinic acid, 5-(p-chlorophenoxy)-, 5-indanyl ester
- 85181-37-9/Benzoic acid, 3,5-dimethoxy-, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl est er, endo-
- 13144-88-2/1-(2,4,4,5,5-pentamethyl-1-cyclopenten-1-yl)ethan-1-one
- 73790-45-1/Hexamethylenebis(tris(dimethylamino)phosphonium iodide)
- 3055-95-6/C12E5
- 161510-57-2/ethyl (5S,8S,9R,10R,13S)-8-benzyl-10-(benzylamino)-9-hydroxy-3,6,11-trioxo-1-phenyl-5,13-di(propan-2-yl)-2-oxa-4,7,12-triazatetradecan-14-oate (non-preferred name)
- 153310-30-6/4-Methylsulfonyl-2,2',3',4',5,5',6-heptachlorobiphenyl
- 11105-31-0/Monel 506
- 68507-45-9/1-(5-O-phosphonopentofuranosyl)-4-thioxo-3,4-dihydropyrimidin-2(1H)-one
- 104987-11-3/Tacrolimus
- 65330-49-6/FRAISION ETHYL ETHER
- 108635-84-3/N-{1-[1-(4-fluorobenzyl)-1H-benzimidazol-2-yl]piperidin-4-yl}pyrimidin-2-amine
- 75225-86-4/Cybrodic acid
- 101255-83-8/1,2,4-trimethyl-3-phenylpyrrolidin-3-yl propanoate
- 21447-39-2/4-[3-[Bis(2-chloroethyl)amino]-4-methylbenzoyl]morpholine
- 55-88-9/2-Octenal, 4-hydroxy-,(2E)-
- 99487-30-6/6-methyl-4-(2-methylphenyl)-2-piperazin-1-ylthieno[2,3-d]pyrimidine hydrochloride
- 79084-83-6/1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-(phenylamino)nicotinonitrile
- 29256-90-4/Cyclohexanediamine
- 153699-23-1/Benzenepropanoic acid,3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxy-, reaction productswith glycidyl methacrylate
- 15821-36-0/6-(but-3-en-1-yl)-1,3,5-triazine-2,4-diamine